Gurpurab Offer - Use Code GURPURAB2023

Register Now

Covovax is approved by DCGI for children aged 7 to 12 years

Published on June 29, 2022
Current Context: The Serum Institute Of India's (SII) Covid-19 vaccine Covovax has been approved by the Drugs Controller General of India (DCGI) for children between the ages group of 7 and 12 years.
Covovax is approved by DCGI for children aged 7 to 12 years
  • As per the recommendation of the expert committee on Covid-19 of the CSDCO DCGI's given approval for emergency use in children.
  • The SEC discussed the EUA application of SII and recommended granting emergency use authorization for Covovax for children aged 7 to 11 years.
  • With this approval, it is almost the last mile covered in the mission of the COVID-19 vaccine for all.
  • Earlier in December 2021, the government had cleared Covovax for restricted use in an emergency in adults and the 12 to 17 years age group.
  • India began inoculating children aged 12-14 years in the past two months.
  • Apart from that, they have also begun administering precautionary doses of vaccines to healthcare and frontline workers and those aged 60 and above.

Question:

Q.1 DGCI has approved which of the following Vaccine for children between the age group of 7 and 12 years?
a. Corbevax
b. Covovax
c. Covaxin
d. Sinopharm

Can I help you?

ramandeep singh

Hey I am Ramandeep Singh. I am determined to help students preparing for RBI, SEBI, NABARD and IBPS exams. Do you want me to help you ?

Join my class here
    Follow me:
Close Menu
Close Menu